293 related articles for article (PubMed ID: 17088865)
1. Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide.
Damrot J; Nübel T; Epe B; Roos WP; Kaina B; Fritz G
Br J Pharmacol; 2006 Dec; 149(8):988-97. PubMed ID: 17088865
[TBL] [Abstract][Full Text] [Related]
2. The HMG-CoA reductase inhibitor lovastatin protects cells from the antineoplastic drugs doxorubicin and etoposide.
Bardeleben RV; Dunkern T; Kaina B; Fritz G
Int J Mol Med; 2002 Oct; 10(4):473-9. PubMed ID: 12239596
[TBL] [Abstract][Full Text] [Related]
3. Lovastatin protects human endothelial cells from killing by ionizing radiation without impairing induction and repair of DNA double-strand breaks.
Nübel T; Damrot J; Roos WP; Kaina B; Fritz G
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):933-9. PubMed ID: 16467108
[TBL] [Abstract][Full Text] [Related]
4. The lipid lowering drug lovastatin protects against doxorubicin-induced hepatotoxicity.
Henninger C; Huelsenbeck J; Huelsenbeck S; Grösch S; Schad A; Lackner KJ; Kaina B; Fritz G
Toxicol Appl Pharmacol; 2012 May; 261(1):66-73. PubMed ID: 22712078
[TBL] [Abstract][Full Text] [Related]
5. Lovastatin protects keratinocytes from DNA damage-related pro-apoptotic stress responses stimulated by anticancer therapeutics.
Ziegler V; Albers A; Fritz G
Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1082-92. PubMed ID: 26876155
[TBL] [Abstract][Full Text] [Related]
6. Mevalonate pathway inhibitors affect anticancer drug-induced cell death and DNA damage response of human sarcoma cells.
Nilsson S; Huelsenbeck J; Fritz G
Cancer Lett; 2011 May; 304(1):60-9. PubMed ID: 21356574
[TBL] [Abstract][Full Text] [Related]
7. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors.
Dubrez L; Goldwasser F; Genne P; Pommier Y; Solary E
Leukemia; 1995 Jun; 9(6):1013-24. PubMed ID: 7596166
[TBL] [Abstract][Full Text] [Related]
8. Evidence that the apoptotic actions of etoposide are independent of c-Jun/activating protein-1-mediated transregulation.
Jarvis WD; Johnson CR; Fornari FA; Park JS; Dent P; Grant S
J Pharmacol Exp Ther; 1999 Sep; 290(3):1384-92. PubMed ID: 10454518
[TBL] [Abstract][Full Text] [Related]
9. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins.
Haendeler J; Hoffmann J; Zeiher AM; Dimmeler S
Circulation; 2004 Aug; 110(7):856-61. PubMed ID: 15289372
[TBL] [Abstract][Full Text] [Related]
10. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.
Choi JW; Jung SE
J Pharmacol Exp Ther; 1999 Apr; 289(1):572-9. PubMed ID: 10087052
[TBL] [Abstract][Full Text] [Related]
11. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
[TBL] [Abstract][Full Text] [Related]
12. Lovastatin attenuates ionizing radiation-induced normal tissue damage in vivo.
Ostrau C; Hülsenbeck J; Herzog M; Schad A; Torzewski M; Lackner KJ; Fritz G
Radiother Oncol; 2009 Sep; 92(3):492-9. PubMed ID: 19615773
[TBL] [Abstract][Full Text] [Related]
13. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.
Dimitroulakos J; Ye LY; Benzaquen M; Moore MJ; Kamel-Reid S; Freedman MH; Yeger H; Penn LZ
Clin Cancer Res; 2001 Jan; 7(1):158-67. PubMed ID: 11205904
[TBL] [Abstract][Full Text] [Related]
14. HMG-CoA reductase inhibitors reduce nicotine-induced expression of cellular adhesion molecules in cultured human coronary endothelial cells.
Cirillo P; Pacileo M; De Rosa S; Calabrò P; Gargiulo A; Angri V; Prevete N; Fiorentino I; Ucci G; Sasso L; Petrillo G; Musto D'Amore S; Chiariello M
J Vasc Res; 2007; 44(6):460-70. PubMed ID: 17657162
[TBL] [Abstract][Full Text] [Related]
15. Delphinidin modulates the DNA-damaging properties of topoisomerase II poisons.
Esselen M; Fritz J; Hutter M; Marko D
Chem Res Toxicol; 2009 Mar; 22(3):554-64. PubMed ID: 19182879
[TBL] [Abstract][Full Text] [Related]
16. Rho GDP dissociation inhibitor protects cancer cells against drug-induced apoptosis.
Zhang B; Zhang Y; Dagher MC; Shacter E
Cancer Res; 2005 Jul; 65(14):6054-62. PubMed ID: 16024605
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress.
Gratia S; Kay L; Potenza L; Seffouh A; Novel-Chaté V; Schnebelen C; Sestili P; Schlattner U; Tokarska-Schlattner M
Cardiovasc Res; 2012 Aug; 95(3):290-9. PubMed ID: 22461523
[TBL] [Abstract][Full Text] [Related]
18. Lovastatin stimulates p75 TNF receptor (TNFR2) expression in primary human endothelial cells.
Nübel T; Schmitt S; Kaina B; Fritz G
Int J Mol Med; 2005 Dec; 16(6):1139-45. PubMed ID: 16273297
[TBL] [Abstract][Full Text] [Related]
19. Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression.
Kah J; Wüstenberg A; Keller AD; Sirma H; Montalbano R; Ocker M; Volz T; Dandri M; Tiegs G; Sass G
Oncol Rep; 2012 Sep; 28(3):1077-83. PubMed ID: 22710979
[TBL] [Abstract][Full Text] [Related]
20. Sodium salicylate is a novel catalytic inhibitor of human DNA topoisomerase II alpha.
Bau JT; Kurz EU
Biochem Pharmacol; 2011 Feb; 81(3):345-54. PubMed ID: 20959117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
